RxDoctor Payments Data

Bert Fichman, MD

Pain Medicine · Lebanon, NHNPI 1508866716

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (58.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Si-bone, Inc. accounts for 66.0% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $9,661 and has fallen 91.7% since, to $804 in 2025. Among pain medicine clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,992in general payments, 2019–2025

Across 81 payments — averaging $185.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Si-bone, Inc.$10K
  • Boston Scientific$2K
  • Medtronic$1K
  • Relievant Medsystems, Inc.$722
  • Nalu Medical, Inc.$278
  • Nevro Corp.$223
  • plus $775 from 14 others

What the payments were for

  • Consulting fees$8,77559%
  • Travel & lodging$2,86819%
  • Food & beverage$3,31122%
  • Education$390%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,992 in reported general payments places this provider in the 90th percentile of 38 pain medicine providers in New Hampshire.

See all pain medicine providers in New Hampshire

Medicare billing

Part B allowed, 2024
$60,228
Medicare patients
193
Services billed
721

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl42$2,001
Buprenorphine13$1,763
Gabapentin137$1,389
Pregabalin16$935
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen42$910
Oxycodone Hcl38$695
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen22$629
Tramadol Hcl18$183
Tizanidine Hcl16$58
Meloxicam23$47

Paid to pharmacies, not to this prescriber.

Other pain medicine in Lebanon

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →